Your session is about to expire
← Back to Search
High Oxygen Delivery for Idiopathic Pulmonary Fibrosis (HOPE-IPF Trial)
HOPE-IPF Trial Summary
This trial will test if patients with IPF can improve their exercise endurance, breathlessness, and quality of life by breathing 60% oxygen during an 8-week exercise training program.
HOPE-IPF Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowHOPE-IPF Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.HOPE-IPF Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- My health condition has been stable for the last 6 weeks.I have been taking more than 10 mg/day of prednisone for over 2 weeks in the last 3 months.I can walk 50 meters or more in 6 minutes.You have a health condition that makes it unsafe for you to do exercise testing, like heart, muscle, or nerve problems.Your lung function tests show that your breathing capacity is very low.You have been in a pulmonary rehabilitation program within the past 6 months.Your oxygen level is 92% or higher when you are resting and breathing normal air.I cannot take nintedanib due to health reasons.I have a health condition besides lung disease that affects my ability to exercise or breathe.I have not taken pirfenidone in the last 4 weeks.I have severe emphysema or my breathing test shows severe lung problem.I am currently taking or have been prescribed nintedanib.I am a good candidate for lung rehab.I am 19 years old or older.I have been diagnosed with Idiopathic Pulmonary Fibrosis.
- Group 1: 60% Oxgyen
- Group 2: Standard of Care
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are being granted admittance to this investigation?
"To fulfil the requirements of this clinical trial, 88 eligible participants need to be enlisted. Participants can choose from two sites: Queens University in Kingston and Alberta, or University of Alberta in Edmonton, Quebec."
Are there any remaining vacancies within this research endeavor?
"Judging by the information posted on clinicaltrials.gov, this research is still in search of participants. It was initially announced on December 1st 2015 and most recently updated May 17th 2022."
How many medical facilities are currently carrying out this clinical trial?
"This research trial has 7 enrolment sites, including Queens University (Kingston), the University of Alberta (Edmonton) and McMaster University in Hamilton. Other locales are also participating."
Share this study with friends
Copy Link
Messenger